FDA accepts Roche's New Drug Application for Xofluza (baloxavir marboxil) for the treatment of influenza in children
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Alle Kategorien
2019 annual financial statements; Adval Tech performed well in 2019
» Report
Jahresabschluss 2019:; Adval Tech hat sich 2019 gut behauptet
» Report
ObsEva SA: New Date Announcement for AGM
» Report
Raiffeisen: Roger Reist übernimmt die Leitung des Departements Treasury & Markets
» Report
Bedeutende Aktionäre - Bedeutende Beteiligungen an Gesellschaften, deren Beteiligungspapiere an SIX Swiss Exchange kotiert sind.
» SIX
Significant shareholders - Significant shareholdings in companies whose equity securities are listed on SIX Swiss Exchange.
» SIX
Actionnaires principaux - Participations importantes dans des sociétés ayant des titres cotés auprès de SIX Swiss Exchange.
» SIX
LafargeHolcim implements action plan regarding Coronavirus pandemic
» Report
Givaudan establishes COVID-19 Communities Fund
» Report
Australia & Canada Added to SGS’s Product Recalls Online Platform
» Report
FDA Issues Temporary Policy for Alcohol Based Hand Sanitizers
» Report
California Proposition 65 Reformulation of DINP in Consumer Products
» Report
2020 ANNUAL GENERAL MEETING OF SIKA AG
» Report
GENERALVERSAMMLUNG 2020 DER SIKA AG
» Report
Federal Reserve offers regulatory reporting relief to small financial institutions affected by the coronavirus
» Report
Federal agencies encourage banks, savings associations and credit unions to offer responsible small-dollar loans to consumers and small businesses affected by COVID-19
» Report
Zur Rose Group AG platziert erfolgreich Wandelanleihe in Höhe von CHF 175 Millionen mit einer Laufzeit bis 2025
» Report
Credit Suisse announces the closing of the transfer of distribution agreements related to its third party investment fund platform Credit Suisse InvestLab to Allfunds
» Report
Edisun Power Europe AG: Résultat record et jalons importants
» Report
